TABLE 2. [11C]Raclopride Nondisplaceable Binding Potential at Baseline and Following AMPT Administration.
| Striatal Subdivision | Treatment Condition | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | AMPT | |||||||||
| Healthy Comparison Subjects (N=15) | Cocaine-Dependent Subjects (N=15) | Unpaired t test (p) | Healthy Comparison Subjects (N=15) | Cocaine-Dependent Subjects (N=15) | Unpaired t test (p) | |||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | |||
| Ventral striatum | 2.12 | 0.26 | 1.88 | 0.29 | 0.02 | 2.37 | 0.26 | 1.96 | 0.38 | 0.002 |
| Precommissural dorsal caudate | 2.25 | 0.16 | 2.01 | 0.34 | 0.02 | 2.49 | 0.19 | 2.11 | 0.40 | 0.002 |
| Precommissural dorsal putamen | 2.62 | 0.26 | 2.39 | 0.31 | 0.04 | 2.93 | 0.30 | 2.51 | 0.36 | 0.002 |
| Postcommissural caudate | 1.34 | 0.15 | 1.31 | 0.26 | 0.67 | 1.54 | 0.20 | 1.45 | 0.30 | 0.33 |
| Postcommissural putamen | 2.59 | 0.22 | 2.35 | 0.34 | 0.03 | 2.96 | 0.25 | 2.54 | 0.42 | 0.002 |
| Striatum | 2.30 | 0.18 | 2.08 | 0.28 | 0.01 | 2.59 | 0.20 | 2.22 | 0.35 | 0.001 |